Preventive Medicine Market

Preventive medicine is a medical practice based on the principle that prevention is better than cure. Preventive medicine can reduce the incidence of non-communicable diseases such as cancer, cardiovascular disease and diabetes.

Preventive Medicine Market contains market size and forecasts of Preventive Medicine in Global, including the following market information:

• Global Preventive Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Preventive Medicine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Public Health and General Preventive Medicine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Preventive Medicine include Novo Nordisk, Eli Lilly, Quanterix, Preventive Medical Health Care, Cancer Prevention Pharmaceuticals, Phoenix Medicine and U.S. Preventive Medicine, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Preventive Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Preventive Medicine Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Preventive Medicine Market Segment Percentages, by Type, 2021 (%)

• Public Health and General Preventive Medicine
• Occupational Medicine
• Military Preventive Medicine

Global Preventive Medicine Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Preventive Medicine Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Others

Global Preventive Medicine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Preventive Medicine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

• The report also provides analysis of leading market participants including:
• Key companies Preventive Medicine revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Preventive Medicine revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novo Nordisk
• Eli Lilly
• Quanterix
• Preventive Medical Health Care
• Cancer Prevention Pharmaceuticals
• Phoenix Medicine
• U.S. Preventive Medicine